SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " Drugs " 570 found 🔀 AI-powered Shuffle
Medicare’s mum on GLP-1s, and Massachusetts sues United
We've been asking Medicare for weeks about the cost of giving seniors $50 obesity drugs.
Weight Loss Drugs Listed By Health Insurers Aren’t Necessarily Covered
Inclusion of weight loss drugs on insurer formularies is a meaningful step towards expanding access. But having a product listed doesn’t necessarily mean it’s covered.
Why Trump reversed course to fast-track psychedelic drugs for mental healthcare
President Donald Trump is trying to fast-track research into psychedelics as treatments, creating new opportunities and risks.
Cisco exec says adopting AI is like 'surgery without the drugs'
Liz Centoni, Cisco's chief customer experience officer, is working to reinvent her 20,000-employee division for the AI era. "It's painful," she says.
Weight-loss drugs like GLP-1s are easy to buy online raising overdose and safety concerns
Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded.
France to reimburse weight-loss drugs from mid-June, health minister says
France will reimburse the cost of weight-loss drugs for severely obese patients from mid-June, Health Minister Stephanie Rist said on Thursday in an interview with TF1 channel.
Expected NC budget won’t restore GLP-1 weight-loss drug coverage for state employees, treasurer says
State Treasurer Brad Briner doesn’t expect North Carolina lawmakers to include funding in the upcoming budget to restore State Health Plan coverage of GLP-1 drugs for weight loss, as costs and competing budget priorities keep the benefit off the table.
Prasugrel after PCI outperforms other common antiplatelet drugs
"Prasugrel provided the optimal balance between efficacy and safety," researchers noted in a new meta-analysis.
Watch Lilly Gets Back Into the Vaccine Business With New Deals
Eli Lilly & Co. is buying three clinical-stage vaccine developers for as much as $3.8 billion as it looks to become a leader in infectious diseases. The drugmaker has been using cash from its obesity drugs to expand into other disease areas. Bloomberg's Gerry Smith reports.
At the Enhanced Games, drugs don’t get athletes banned. They could get them rich.
The inaugural Games took place Sunday in Las Vegas, where aging Olympians competed for large payouts, most of them after having taken cocktails of performance-enhancing drugs.
Common heart drug taken by millions found useless
A massive international study could upend 40 years of heart attack treatment. Researchers found that beta blockers—routinely prescribed after uncomplicated heart attacks—offered no real benefit for patients whose heart function remained normal, despite being given to millions worldwide. Even more surprising, women taking the drugs faced a higher risk of death, repeat heart attack, or hospitalization for heart failure compared to women who didn’t receive them.
Scientists discover why Ozempic and Wegovy weight loss eventually plateaus
New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.
How the Silicon Valley-backed steroid Olympics aim to get everyone hooked
As biohacking gains momentum among elites including Robert F. Kennedy Jr., the Peter Thiel-backed Enhanced Games aims to normalize longevity drugs through a Vegas sports spectacle. Critics call the premise dangerous and unethical.
AI scans 400,000 Reddit posts and finds hidden Ozempic side effects
By analyzing over 400,000 Reddit posts, researchers discovered that users of popular GLP-1 weight-loss drugs frequently discussed unexpected symptoms like menstrual irregularities, chills, and hot flashes. The findings suggest AI could turn social media into a powerful early-warning system for spotting side effects that clinical trials may miss.
Bond breakout? Big effects of bad data. Immigration and thermostatic politics & dad-chat is coming for dad-books.
Thank you for opening your Chartbook email. Anna Airy, A Shell Forge at a National Projectile Factory, Hackney Marshes, London, 1918 Bond breakout - John Authers Across the developed markets, bond markets are staging a slow-motion car wreck. Looking at the drastic moves in the US, Japan, the UK and France, Barclays’ Ajay Rajadhyaksha commented: “Last week, long bonds broke. Not in one country. In all of them. Simultaneously. Four countries. Four different political systems. Four different central banks. But the same trade — “get me out of duration!”” Each country has its own contributing political problems, but the uniformity of the shift out of long-term bonds with high duration makes clear that something broader is afoot. For Rajadhyaksha, it is “simple and uncomfortable.” The developed world “has too much debt, too little fiscal discipline, and no political appetite for fixing either.” If there’s a trigger, it has been the Iran war and the resulting shock to oil supply. Source: Bloomberg G7 countries are now borrowing at rates that were enjoyed by EM in the early 2020s For contributing subscribers only. Subscribe Trade between China and Russia has grown in recent years For contributing subscribers only. Subscribe Big effects of bad data A decade ago nearly nine in ten Americans, when approached, agreed to fill out the Current Population Survey, which is administered to about 60,000 households each month and asks about, among other things, employment. Fewer than seven in ten do so now (see chart 1). For the Consumer Expenditure Survey, which tries to capture 3,700 households monthly, the response rate is down from 68% to 40%. … When the information becomes less reliable, investment decisions get more difficult to make. Some may be delayed, creating a potential drag on the economy. A new working paper by Nicholas Bloom of Stanford University, Erica Groshen, former head of the Bureau of Labour Statistics (BLS) now at Cornell University, and Duncan Hobbs and Michael Strain of the American Enterprise Institute, a think-tank, hazards an estimate. Preserving trust in “the integrity and quality of official statistics”, the authors claim, generates economic benefits of about $25 for every $1 spent on the BLS, the agency with an annual budget of $700m that is responsible for many of these data. To arrive at their conclusion the quartet analysed an ignoble episode in the BLS’s recent history. On August 1st 2025 Donald Trump sacked Erika McEntarfer, appointed as the agency’s commissioner by his predecessor, Joe Biden. The president alleged, without evidence, that the BLS’s steep downward revision to recent jobs numbers had been “RIGGED in order to make the Republicans, and ME, look bad”. In fact, it was the wanton dismissal that looked bad in the eyes of many observers. In the following seven days there was a 50% leap, relative to the week before, in the average value of the index of Economic Policy Uncertainty (EPU), which tracks the number of articles mentioning such uncertainty that are published daily in American newspapers. This was a discernible jump even when compared to the chaos caused by Mr Trump’s trade war in April 2025 and his real one in Iran in the past two months (see chart 2). Based on Mr Bloom’s earlier study with other colleagues of the EPU’s impact on business investment, industrial production and employment, the authors estimate that the jump reduced American GDP by over $100bn (0.3%) and non-farm payrolls by 168,000 (0.1%). Source: The Economist Immigration and thermostatic politics (Sarah O’Connor in the FT) A strange thing happened a year and a half ago. No sooner had Americans elected Donald Trump as president on an explicitly anti-immigration platform than US public opinion began to swing much more favourably towards immigration. … to political scientists who study “thermostatic” politics, this development is no surprise at all. Public opinion often moves against the prevailing party, especially if they are perceived to have gone “too far” in one direction. The phenomenon was first explored in the 1990s with reference to fiscal policy, but in recent years it has been particularly evident in the realm of immigration policy. While these swings in opinion polls can make it seem as if people don’t know their own minds, they can be a useful democratic check on governments by sending bright flashing warning lights when policies stray too far from the public’s comfort zone. The problem comes when politicians misinterpret those signals. When people tell pollsters they want less immigration, or think it is bad for the country overall (or the converse), they are often expressing an opinion about how things appear to be going in that moment relative to their preferences, rather than a deep shift in their underlying views. According to Alexander Kustov, a political scientist, most Americans’ views are quite stable and moderate: they support immigration that is controlled and in the national interest, and oppose flows that are disorderly or under-enforced. In the US, he argues the Trump administration over-interpreted dissatisfaction with high immigration under Joe Biden, and implemented policies that went too far for many voters. “People don’t necessarily change their idea about their ideal immigration policy, but they can react to what the government is currently doing,” he told me. “A lot of people are not happy with what the Trump administration are doing — right now we’re not talking about border enforcement, we’re talking about people not just getting harassed, but killed.” But similarly, he added, pro-immigration advocates would be making a mistake to interpret the recent, more favourable swing towards immigration as a deep-seated ideological shift in attitudes. The recent history of UK immigration policy offers another cautionary tale. After the 2016 Brexit referendum, public concern about immigration fell. This was partly because net migration statistics declined, but also because people felt a sense of catharsis and control, says Sunder Katwala, director of British Future, a think-tank. By 2019, the public ranked immigration as only the ninth biggest issue of concern, according to Ipsos polling. But when the Conservative government liberalised visa routes for students and care workers between 2019 and 2022, that helped net migration to surge. And so, too, did public concern. Today’s Labour government has implemented another sharply restrictive turn in immigration policy. As Kustov and researcher Caitlyn Yates argue, thermostatic public opinion should be a useful check on politicians. Instead it seems to have helped to magnify the pendulum swing in the UK. The government over-interprets and overreacts to a change in public opinion, which reacts in turn, prompting a sudden swing the other way. Source: Financial Times HEY READERS, THANK YOU for opening the Chartbook email. I hope it brightens your day. I enjoy putting out the newsletter, but tbh, what keeps this flow going is the generosity of those readers who clicked the subscription button. If you are persuaded to click, please consider the annual subscription of $50. It is both better value for you and a much better deal for me, as it involves only one credit card charge. Why feed the payments companies if we don’t have to. Subscribe Anna Airy, Shop for Machining 15-Inch Shells: Singer Manufacturing Company, Clydebank, Glasgow, 1918 Racing for a vaccine … we have been here before! The deadly Ebola outbreak in two African countries driven by a virus species with no vaccine has triggered an urgent search for a potential jab, in a test of troubled global efforts to avert threats posed by emerging diseases. A World Health Organization advisory group is due to would meet on Tuesday to recommend candidate jabs to prioritise for clinical trials, the global health body said. It will assess data including an analysis by the Coalition for Epidemic Preparedness Innovations (Cepi), which was set up after failures in the international response to a previous Ebola crisis. The latest Ebola outbreak in Democratic Republic of Congo and Uganda has infected hundreds of people and killed more than 80, health authorities say. Cepi’s reaction will be a crucial indicator of its progress towards its wider goal of producing vaccines for pandemic threats in just 100 days, despite steep cuts to international health funding. “If there was ever a time that we could show the world why Cepi is needed and show the world why the 100-day mission is needed, it’s now,” Nicole Lurie, the organisation’s executive director for preparedness and response, told the FT. “We’re happy to accept that responsibility, but obviously we need help from partners — particularly financial help in the long run.” DR Congo and Uganda would make the final decision on whether to press ahead with any vaccine candidates endorsed for clinical trials by the WHO experts, the global health body said. “Other ethical and community acceptability issues will be considered,” said the WHO, which declared the latest outbreak a public health emergency of international concern on Sunday. “This will be important to make sure that the trial, if it happens, will be adequately communicated to the population.” Lurie said Cepi had provided information from a survey of research teams and companies working on drugs that might be effective against the Bundibugyo virus behind the outbreak. The organisation hoped soon to announce partners in the quest for a jab, she added, although she declined to give a timescale for when one might be developed. Cepi’s Nicole Laurie said global health bodies were ‘getting some live-fire drills’ with hantavirus and the latest Ebola outbreak. The hunt for a vaccine should be helped by scientific advances including the use of artificial intelligence to find drugs active against viruses, Lurie said. Existing jabs against the Zaire Ebola virus responsible for many previous outbreaks might provide a basis for tackling the Bundibugyo species, she added. “We’ll see how far and how fast we can get,” Lurie said, adding that Cepi had done preliminary work recently on a possible jab for the rat-borne hantavirus responsible for a recent fatal outbreak on a cruise ship. “Both with hantavirus and now with Ebola, [we] are getting some live-fire drills.” Source: Michael Peel in the Financial Times Dad-chat is coming for dad-books. (By Pamela Paul and Jeffrey A. Trachtenberg in the WSJ) They were the go-to gifts for Father’s Day: a book about some little-known chapter of World War II, the sweeping narrative of a shipwreck, perhaps the latest presidential biography. These days, dad books are a dying breed. Nonfiction book sales have been in decline for the past four years, and are now the most challenged segment of the print book market. Publishers say certain types of books still fare well—including celebrity memoirs and religious titles. But in recent years, print sales in such categories as biography, current affairs and business and economics—what publishers refer to as “serious nonfiction” and which tend to resonate especially with men—have fallen considerably. Sales of nonfiction print titles were down nearly 8% through May 9 this year, and sales of books about politics and current affairs were down 19%, according to book tracker Circana BookScan. Publishing has long been subject to cyclical changes, with trends in format and genre taking over bookshelves in grand sweeps. (Remember the adult coloring-book craze? Or the stratospheric rise of romantasy?) But many in publishing believe the decline in serious nonfiction is more existential. “The trend couldn’t be clearer,” said Jonathan Karp, the former chief executive of Simon & Schuster and publisher of the new Simon Six imprint. “This is a sea change and people should wake up and realize we’re living in a new world.” One culprit for the shift: a new media diet for fans of more serious nonfiction. … Sixty-two percent of men and 54% of women consumed a podcast in the prior month, according to a recent survey by Edison Research at SSRS, up from 46% and 39%, respectively, in 2023. “When we have internal meetings to talk about this problem, it always comes around to podcasts,” said Jonathan Burnham, president and publisher of the Harper Group at HarperCollins Publishers. “The man who wants to read American history is now tuning into one of the many good podcasts about history that lends the quiet attention to a serious subject he’s looking for. It makes the idea of sitting down with a 700-page Ron Chernow book less appealing. You’ve scratched that itch.” Source: Wall Street Journal Remarkable report by Novara from the nationalist rally in London in mid May. Anna Airy, Leopard Moth and Plums, 1915 If you’ve scrolled this far, you know you want to click: Subscribe
People with eating disorders are taking GLP-1s and doctors are alarmed
Providers said they are encountering patients seeking treatment for anorexia, bulimia and binge eating disorder who are taking GLP-1 drugs.
Inflammation may help explain how GLP-1 drugs prevent AFib
Kenneth Bilchick, MD, spoke to Cardiovascular Business about new data he presented at Heart Rhythm 2026.
GLP-1 Drugs Are Causing Frailty | Health for May 22
Plus, why one writer wants everyone to bail on Botox and how natural food colors are linked to health problems
A new sporting event’s controversial pitch: Performance-enhancing drugs welcome
The Enhanced Games, taking place this weekend in Las Vegas, support “safe, responsible, and clinically supervised use of performance enhancements.”
5 Notable Moments From Candace Owens’s Warm Interview With Hunter Biden
In a nearly two-hour conversation, Mr. Biden discussed his addiction to drugs and alcohol, and Ms. Owens apologized for her past remarks about him.
Popular weight loss drugs like Wegovy may also target arthritis inflammation
Researchers have discovered that the GLP-1 hormone targeted by drugs like Wegovy is present in very low amounts inside the joints of arthritis patients. That finding suggests high-dose GLP-1 medications could potentially reach the joints and influence inflammation directly, not just help through weight loss. Scientists say this could open the door to a completely new approach to arthritis treatment.
Popular Weight Loss Drugs May Have Surprising Side Effect: Stalling Cancer
A suite of new studies suggest drugs such as Ozempic and Zepbound might slow tumor progression and improve survival, but more research is needed to confirm the findings.
Welcome to the Enhanced Games, where doping is encouraged
The Enhanced Games are here to destigmatize conventional wisdom about performance enhancing drugs.
Drug-enhanced sports: 'Clown show' or the future?
More than 40 athletes, most using performance-enhancing drugs, will compete in the Enhanced Games in a competition that seeks to upend sporting norms.
Dartmouth Health study could point way to sustained weight loss for those who stop using GLP-1 drugs
GLP-1 drugs have transformed obesity treatment, but many patients regain weight after stopping the medication. A new study could point the way to a solution.
What Is ‘Ozempic Personality’? Patients Say GLP-1 Left Them Emotionally Flat
Some patients taking GLP-1 weight-loss drugs report less pleasure and excitement in life. “It is not in their heads,” doctor says. How to get help if you’re feeling less joy on the medication.
What we know about the 2026 Ebola outbreak as first American tests positive
The type of Ebolavirus causing the outbreak in DRC, called Bundibugyo, is less common than other types of Ebola. There are no vaccines or drugs available to treat it.
Science Says People Who Lose Weight on GLP-1 Drugs Face More Stigma Than People Who Stay Overweight. That's Just Weird
I have thoughts.
Puberty field trip? Philly-area students get a front-row seat to health education
Lankenau Medical Center’s health education center provides free interactive programs on nutrition, exercise, drugs and alcohol, puberty and more.
Routine testing is needed to locate patients who may not benefit from clopidogrel
Up to 30% of U.S. patients carry genetic variations that reduce the effectiveness of clopidogrel, an antiplatelet medication sold under the brand name Plavix.
Joe Rogan podcast appearance tied to rise in demand for alternative cancer treatment
Ivermectin prescriptions spiked among cancer patients after Mel Gibson endorsed antiparasitic drugs on Joe Rogan's podcast, a new JAMA study reports.
An unloved health-care stock gets a welcome nod in this AI-obsessed market
Leerink analysts lifted J&J shares to a buy equivalent from hold on Wednesday, citing the company's slate of new drugs.
AI Life Science Firm Metis TechBio Set for HK Debut After IPO
Metis TechBio Co, a biotechnology company using artificial intelligence to deliver and formulate drugs, is set to begin trading in Hong Kong after raising HK$2.1 billion ($270 million) in an initial public offering.
New drugs could wipe out the “zombie cells” linked to cancer and aging
Researchers found a new way to kill harmful “zombie” cells that linger after chemotherapy and help cancers become more aggressive. These senescent cells survive by relying on a protective protein called GPX4, even while sitting on the edge of a deadly iron-triggered collapse. New drugs remove that protection, causing the cells to self-destruct. In mice, the approach reduced tumor size and boosted survival, hinting at a promising new cancer therapy.
Obesity Drug Prices Undercut Healthcare Savings, CVS CEO Says
CVS Health Corp. Chief Executive Officer David Joyner said that drugmakers must significantly reduce the price of anti-obesity medicines before the drugs will save money for commercial health insurance plans.
Why Swedish scientists gave salmon cocaine
A recent study caught our eye: salmon on cocaine. Or really, researchers giving salmon cocaine…for science. See, scientists know human drugs pollute aquatic environments – past studies have shown even anti-anxiety drugs can change how fish act. But illicit drugs are less studied. And Jack Brand, an aquatic ecologist at the Swedish University of Agricultural Sciences, wanted to know how illicit drugs like cocaine might change fish behavior, like foraging and mating. To answer that question, Jack and his team gave salmon cocaine. Interested in more science? Email us your question at shortwave@npr.org.Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.
Medicare’s miss on Alzheimer’s drug spending
Far fewer seniors than expected are taking costly Alzheimer's drugs.
Greater weight loss from GLP-1 drugs lowers health complication risk
New research to be presented at this year's European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May) shows that, following treatment for obesity or diabetes or both using incretin-based drugs, losing more weight versus less weight, and losing a little weight versus gaining weight, both lead to relatively lower risk of obesity-related conditions.
Health economist analyzes Trump’s deal for cheaper drugs
Exclusive: Kennedy's health officials explored US ban of some widely used antidepressants, sources say
U.S. health department officials last week explored whether they could ban certain drugs in a widely prescribed class of antidepressants as Health Secretary Robert F. Kennedy Jr. prepared to roll out a plan to reduce their use, according to two people familiar with the discussions.
Can blockbuster GLP-1 weight-loss drugs also protect brain health?
UCSF experts share their research on medications’ potential to slow or reduce risk of dementia and to treat the triggers that drive addiction.
Khloé Kardashian Says She Was Drugged at a Coachella Party: ‘I Was So Scared’
"I don't think anyone drugged me," she revealed on her podcast. "I just think I was the dumb one and didn't realize everyone was on drugs"
Tonopah business owner arrested for alleged drug possession
A business owner in Tonopah has been arrested after police say he was found with drugs.
RFK Jr. launches plan to curb ‘overprescribing’ of psychiatric drugs
Robert F. Kennedy Jr. announced federal efforts to limit overprescribing and support deprescribing of psychiatric drugs, including antidepressants.
Researchers are giving salmon cocaine. Don't worry, it's for science
With cocaine and its metabolite, benzoylecgonine, being detected in waterways across the globe, Canadian researcher Erin McCallum and her team set out to understand the impact of these illicit drugs on fish in Sweden.
The dark side of weight loss drugs: Ozempic's surprising hidden cost
GLP-1 weight-loss drugs like Ozempic and Wegovy are often celebrated as game-changing solutions—but new research reveals a surprising social twist. People who lose weight using these medications may actually face more judgment than those who lose weight through diet and exercise—or even those who don’t lose weight at all. The stigma seems rooted in a perception that these drugs are an “easy way out,” creating a double bind where individuals are judged both for their weight and for how they choose to manage it.
The scientist designing a tailored attack on glioblastoma
At UCLA, Dr. David Nathanson develops drugs that target the unique biology of glioblastoma, offering new hope for patients with this aggressive cancer.
How Republicans came to embrace psychedelic drugs
After decades of backing a “war on drugs,” the GOP has warmed to psychedelics for mental health treatment as high-profile backers and veterans tout the drugs.
Helene frayed the safety net for people who use drugs. This community wove it back together.
Harm reduction groups and health care workers helped avert the worst. But what about the next emergency?
Weight loss drug Ozempic linked to lower depression and anxiety risk
GLP-1 drugs like semaglutide—best known for treating diabetes and driving weight loss under the brand names Ozempic and Wegovy—may also deliver a surprising mental health boost. In a massive study tracking nearly 100,000 people over more than a decade, researchers found that these medications were linked to significantly fewer psychiatric hospital visits and sick days.
Alzheimer’s drugs may not work and could raise brain risks
Drugs designed to clear amyloid beta from the brain—once seen as a promising path to slowing Alzheimer’s—may not actually help patients in any meaningful way, according to a major review of over 20,000 participants. Even more concerning, they may increase the risk of brain swelling and bleeding, sometimes without obvious symptoms.
Republicans see high-risk plans as the future of health insurance
More than 40 million Americans are already opting to take on the cost of sick visits, drugs and surgeries to get lower premiums and tax savings.
Scientists discover new enzyme that could supercharge weight-loss drugs
Researchers at the University of Utah have discovered an enzyme called Pap B that will chemically change and update drugs like Ozempic and Wegovy making them stronger and last longer.
Appeals court blocks FDA rule that allows women to obtain abortion drugs by mail
A federal appeals court temporarily reinstated a nationwide requirement that abortion pills be obtained in person, undermining access to the method of abortion that has only grown more widespread since the US Supreme Court overturned Roe v. Wade.
Surgery still outperforms GLP-1 drugs in terms of heart health
Both treatment options are effective, but metabolic and bariatric surgery was linked to more significant cardiovascular risk reductions than GLP-1 medications.
Science news: Return of the river-herring run, Musk vs. Altman and new pancreatic cancer drugs
Under the Radar breaks down the latest science and technology headlines, including communities fighting back against data centers, overheated sharks and more
Big Pharma throws support behind Ashley Moody in US Senate race
A number of pharmaceutical companies had their drugs removed from a list slated for price reduction negotiations with Medicare officials, thanks to legislation that Moody supported.
Are all our politicians on drugs? No. Yet it is fair to say some may occasionally attend work refreshed
Gor blimey it smells like a brewery
PwC will drop cover for weight-loss drugs from employee health plans
Big Four accountancy balks at high cost of medication it says has become ‘cultural phenomenon’
New treatment cuts bad cholesterol by nearly 50% without statins
A new breakthrough could change how high cholesterol is treated, offering a powerful alternative to traditional drugs. Researchers have developed tiny DNA-based molecules that shut down PCSK9—a key protein that keeps “bad” LDL cholesterol circulating in the blood. By blocking this protein, cells can absorb more cholesterol instead of letting it build up in arteries, dramatically lowering levels linked to heart disease.
Britney Spears charged with driving under the influence of alcohol and drugs
Britney Spears was charged in California on Thursday with driving under the influence of drugs and alcohol, authorities said.
Britney Spears charged with driving under the influence of alcohol and drugs
Spears was charged in California Thursday
Cardinal Health lifts annual profit forecast on strong demand for specialty drugs
Drug distributor Cardinal Health on Thursday raised its 2026 profit forecast range, betting on strong demand for costly specialty medicines and branded drugs at its pharmaceuticals unit.
Protect patient access to life-saving drugs
By Leslie Herod Since its inception, Colorado’s Prescription Drug Affordability Board (PDAB) created fear among patients around effects to life-saving medicines and the negative ramifications price controls have on affordability. Five years on, those fears persist. Patients and advocates continue to push for protections for those facing the very likely scenario drugs whose price is […]
‘The energy behind these drugs has moved from the beatniks to biohackers’
Opinion, comment and editorials of the day
Trump administration reverses on paying for fentanyl detection strips
The Trump administration is no longer allowing federal funds to be used for purchasing or distributing test strips that can determine if street drugs ha…
MIT scientists turn chaotic laser light into powerful brain imaging tool
Scientists at MIT discovered that chaotic laser light can spontaneously form a highly focused beam instead of scattering—if the conditions are just right. This “pencil beam” enabled them to image the blood-brain barrier in 3D at speeds 25 times faster than existing techniques. The method also lets researchers watch how drugs move into brain cells in real time. It could dramatically accelerate the development of treatments for neurological diseases.
U.S. Government Will Stop Paying for Test Strips to Detect Deadly Drugs
In a letter to states and other grant recipients, the Trump administration says the strips encourage drug use.
What to know about psychedelic retreats, a booming business
Surging interest in the purported benefits of psychedelic drugs has given rise to a new industry: psychedelic retreats
Multiple GLP-1 drugs linked to lower AFib risk
The popular drugs, originally developed to treat diabetes, were also associated with an improved survival rate. Benefits were seen in patients who did and did not lose significant weight as a result of treatment.
Drug use in England spikes during heatwaves and big sports events, research finds
Project that tested traces of illicit drugs in wastewater also found higher use during Eurovision song contest
Patients taking weight-loss drugs often make 5 critical mistakes, doctor warns
Experts say GLP-1 drugs offer benefits beyond weight loss, but common mistakes like skipped labs and poor nutrition can undermine results or cause harm.
What is ibogaine? FDA to fast-track review of drugs for mental health
DCSO: Suspect arrested while shipping drugs at local business
Detectives arrested 41-year-old Ryan Lehan of Owensboro while he was attempting to ship out those drugs at a local business.
What to know about psychedelic retreats, a booming business with few safety guardrails
Virtually all the drugs offered at retreats are illegal under U.S. federal law.
What to know about psychedelic retreats, a booming business with few safety guardrails
Virtually all the drugs offered at retreats are illegal under U.S. federal law.
The podcast telling the stories behind Ambien, Ozempic, EpiPens, and other game-changing drugs
“We're basically not using our body as directed,” says "Drug Story" host Thomas Goetz.
FDA fast-tracking its review of two psychedelic drugs for mental health treatments
Hallucinogenics are illegal under federal law but that isn’t stopping the FDA from fast tracking 3 psychedelic drugs to treat mental health
Last week, President Donald Trump signed an executive order directing the FDA and other federal agencies to speed research and loosen restrictions on psychedelics, a class of hallucinogenic drugs which remain illegal under federal law.
FDA moves to fast-track review of psilocybin and methylone for mental health
Some psychedelic drugs, once considered fringe, are now getting a step closer to possibly being approved for use as mental health treatments in the United States.
Big business shows up in final days of arguments at Supreme Court
Big businesses are lining up at the Supreme Court as the justices hear the final arguments of the term, pressing the conservative majority to shield industries from multimillion-dollar jury verdicts, limit the marketing of generic drugs and neuter the government’s ability to issue fines.
Big business shows up in final days of arguments at Supreme Court
Big businesses are lining up at the Supreme Court as the justices hear the final arguments of the term, pressing the conservative majority to shield industries from multimillion-dollar jury verdicts, limit the marketing of generic drugs and neuter the government’s ability to issue fines.
Marijuana's reclassification raises new questions for the cannabis industry
Medical marijuana is moving from Schedule I status, reserved for the most dangerous drugs like heroin and LSD, to Schedule III, like testosterone and steroids, which are less strictly regulated.
Speed over science?
A new executive order could fast-track approval of psychedelic drugs for mental illness, raising hopes for breakthrough treatments while prompting…
Amazon launches weight loss drug program
Demand for weight loss drugs is ballooning across the U.S. — and Amazon wants in.
Ibogaine is drawing new interest from the Trump administration. Here’s what to know about the psychedelic
Psychedelic drugs, once pushed to the fringes of medicine, are gaining serious attention within the Trump administration as potential treatment options for people with certain mental health conditions. And they could soon be closer to receiving approval from the US Food and Drug Administration.
Americans killed in Mexico car crash following drug raid worked for the CIA, sources say
The two US embassy officials who died in a car accident in Mexico on Sunday worked for the CIA and had been collaborating with Mexican officials on expanded counternarcotics operations in the country, two people briefed on the matter confirmed to CNN.
Alzheimer’s drugs offer little benefit, major review finds – and the reasons go deeper than the science
Alzheimer’s research shows what happens when funding pressures and vested interests corrupt the pursuit of scientific truth.
Binghamton native announces plans for new entertainment venue
BINGHAMTON, N.Y. (WIVT/WBGH) -A Binghamton native who had a successful career in finance in the Boston area is looking to invest in his hometown. Nate Levy recently purchased the former CVS drugstore ...
Trump’s order on psychedelics could have far-reaching science consequences
A new executive order could make it easier for researchers studying how psychedelic drugs like psilocybin, LSD and ibogaine may be useful in medicine
President Trump’s Landmark Order Advances Breakthrough Mental Health Treatments — Delivering New Hope to Veterans
This weekend, President Donald J. Trump signed a groundbreaking Executive Order accelerating research and improving access to psychedelic drugs as
Trump Backs Psychedelic Research
By HealthDay Staff HealthDay ReporterMONDAY, April 20, 2026 (HealthDay News) — Psychedelic drugs could soon play a larger role in mental health care. Over the weekend, President Donald Trump signed an executive order aimed at boosting federal research into substances like psilocybin, LSD and MDMA
Our latest list of Chicago’s largest private companies has a newcomer near the top
Last year's private equity buyout made drugstore giant Walgreens the Chicago area's second-largest privately held company. This year's list is also missing one of its regulars.
Blockbuster GLP-1 Diabetes and Weight Loss Drugs Fails in Alzheimer’s Trial
Researchers are exploring whether GLP-1 medications used for diabetes and weight loss could treat Alzheimer’s and addiction.
Trump signs order to hasten review of psychedelics
Ibogaine and other psychedelics remain banned under the federal government's most restrictive category for illegal, high-risk drugs. But the administration is taking steps to ease restrictions and spur research on using the drugs for medical purposes, including conditions like severe depression.
Trump accelerates research on psychedelic treatments and asks, ‘Can I have some?’
President Donald Trump on Saturday signed an executive order aimed at encouraging expanded research into ibogaine and other psychedelic drugs, part of a broader push to explore emerging mental health treatments.
Trump signs order to speed up review of psychedelic drugs for mental health treatment
The order eases restrictions on psychedelic drugs like ibogaine to spur research on using the them for medical purposes.
Trump signs order to speed review of psychedelics, including the controversial drug ibogaine
President Donald Trump has directed his administration to speed up reviews of certain psychedelic drugs, including ibogaine | WBEN
Trump signs order to speed review of psychedelics, including the controversial drug ibogaine
President Donald Trump has directed his administration to speed up reviews of certain psychedelic drugs, including ibogaine.